Skip to main content
Clinical Trials/NL-OMON50381
NL-OMON50381
Recruiting
Not Applicable

ovel transcatheter arterial embolization for treatment of knee osteoarthritis: a randomized sham-controlled clinical trial - Transcatheter arterial embolization treatment of knee osteoarthritis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
degeneration of joint cartilage
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
58
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age \* 18 years
  • \- Knee pain for a duration of \*6 months
  • \- Knee pain (numeric rating scale \*4 \- \*8\) on at least half of the days in the
  • preceding month at
  • time of inclusion
  • \- There is insufficient response of conservative treatment for at least 6 months
  • \- Radiographic knee osteoarthritis (radiographic Kellgren and Lawrence grade

Exclusion Criteria

  • \- Contra\-indications for MRI (e.g. metallic foreign bodies, etc.)
  • \- Contra\-indications for angiography
  • \- Renal insufficiency, checked with blood sample test (GFR \< 30 ml/min/1,73 m²);
  • \- Known allergy to contrast agents;
  • \- Patient has known allergies to barium sulfate, 3\-aminopropyltrialkoxysilane,
  • polyphosphazene
  • \- Women who are pregnant or lactating
  • \- Intermittent claudication of affected limb
  • \- Intra articular injections in the ipsilateral knee less than 6 months ago
  • \- On the waiting list for joint replacement surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials